The development of a sleep disorder screening program in Australian community pharmacies

Tran, Adam; Fuller, Joanne M.; Wong, Keith; Krass, Ines; Grunstein, Ron; Saini, Bandana

doi:10.1007/s11096-009-9301-4

Cited by 32 publications

(48 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the pharmacists in this study readily referred patients to see a GP following the unsuccessful management of insomnia. This might be due to several factors such as increased awareness about sleep disorders following several successful sleep health-promotion programs (Tran et al 2009;Fuller et al 2011) or the recognition by pharmacists of the limitations in their capacities to diagnose and manage insomnia as there are often increased options for management available through the GP.…”

Section: Discussionmentioning

confidence: 99%

“…Although the implementation of non-pharmacological strategies was limited solely to advice concerning sleep hygiene, it does suggest that GPs and pharmacists are not averse to the concept. In fact research has shown that primary health practitioners do perceive the benefits of non-pharmacological therapies but often lack the resources and training to use those interventions (Tran et al 2009;Anthierens et al 2010). This is a potential issue facing the participants in our study given the lack of clarity on nonpharmacological treatment approaches for insomnia in the available management guidelines.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Primary health care practitioner perspectives on the management of insomnia: a pilot study

Cheung

Atternäs

Melchior

et al. 2014

Aust. J. Prim. Health

Self Cite

View full text Add to dashboard Cite

Abstract. This paper reports a qualitative pilot study exploring primary care health practitioners' perspectives on the management of insomnia following the extensive media coverage on the adverse effects of zolpidem in 2007-08. General practitioners and community pharmacists were recruited throughout metropolitan Sydney, New South Wales using a convenience sampling and snowballing technique. Demographic information was collected from each participant followed by a semistructured interview. In total 22 participants were interviewed, including eight general practitioners and 14 community pharmacists. Interview transcripts were analysed using 'framework analysis'. Participants' responses illuminated some of the key issues facing primary care practitioners in the management of insomnia. Practitioners perceived there to be an overreliance on pharmacotherapy among insomnia patients and inadequate support for directing patients to alternative treatment pathways if they require or prefer non-pharmacological management. Current prescribing trends appear to favour older benzodiazepines in new cases of insomnia whereas some successful sporadic users of zolpidem have continued to use zolpidem after the media coverage in 2007-08. The findings of this pilot study suggest the need to address the limitations in the management of insomnia within the current health care system, to revise and disseminate updated insomnia guidelines and to provide educational opportunities and resources to primary care practitioners concerning management options.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Primary health care practitioner perspectives on the management of insomnia: a pilot study

Cheung

Atternäs

Melchior

et al. 2014

Aust. J. Prim. Health

Self Cite

View full text Add to dashboard Cite

show abstract

“…Studies have shown that pharmacists may be successfully trained to identify patients who are at risk for developing sleep disorders, and the community pharmacy is an ideal location for assisting "at-risk" patients. 4,14 Studies conducted by Tran et al 9 in 2009, and in 2011 by Fuller et al 14 have investigated the use of sleep assessment tools in Australian community pharmacies. These previous studies suggested that the use of a sleep tool in a pharmacy setting is viable and feasible.…”

Section: Discussionmentioning

confidence: 99%

“…7 Community pharmacies are often the most easily accessible health care locations in the community; therefore, they are often the first point of care for individuals with self-perceived sleep problems. 4 Studies have shown that pharmacists may be successfully trained to identify patients who are at risk for developing sleep disorders; 4,9 however, there are currently no specific tools available for use by Australian community pharmacists to determine those at risk. An assessment device or tool must be time-efficient, cost-effective, and practical, in order to be readily incorporated into the busy community pharmacy environment.…”

mentioning

confidence: 99%

“…12 Limited studies have trialed sleep disorder screening across international community pharmacies. 4,9,14,15 Several successful feasibility trials examining sleep disorder screening have been undertaken in Australia by Fuller et al; 9,14,15 however, no single, pharmacy-administered, standardized questionnaire or scale for the assessment of sleep disorder risk in the community has been nationally implemented, 12,13,16 thus presenting a clinical and research gap.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Can a community pharmacy sleep assessment tool aid the identification of patients at risk of sleep disorders in the community: a pilot study

Kashyap¹,

Nissen²,

Smith³

et al. 2012

IPRP

View full text Add to dashboard Cite

Background: When experiencing sleep problems for the first time, consumers may often approach community pharmacists for advice as they are easily accessible health care professionals in the community. In Australian community pharmacies there are no specific tools available for use by pharmacists to assist with the assessment and handling of consumers with sleep enquiries. Objective: To assess the feasibility of improving the detection of sleep disorders within the community through the pilot of a newly developed Community Pharmacy Sleep Assessment Tool (COP-SAT). Method: The COP-SAT was designed to incorporate elements from a number of existing, standardized, and validated clinical screening measures. The COP-SAT was trialed in four Australian community pharmacies over a 4-week period. Key findings: A total of 241 community pharmacy consumers were assessed using the COP-SAT. A total of 74 (30.7%) were assessed as being at risk of insomnia, 26 (10.7%) were at risk of daytime sleepiness, 19 (7.9%) were at risk of obstructive sleep apnea, and 121 (50.2%) were regular snorers. A total of 116 (48.1%) participants indicated that they consume caffeine before bedtime, of which 55 (47%) had associated symptoms of sleep onset insomnia. Moreover, 85 (35%) consumed alcohol before bedtime, of which 50 (58%) experienced fragmented sleep, 50 (58%) were regular snorers, and nine (10.6%) had apnea symptoms. The COP-SAT was feasible in the community pharmacy setting. The prevalence of sleep disorders in the sampled population was high, but generally consistent with previous studies on the general population. Conclusion: A large proportion of participants reported sleep disorder symptoms, and a link was found between the consumption of alcohol and caffeine substances at bedtime and associated symptoms. While larger studies are needed to assess the clinical properties of the tool, the results of this feasibility study have demonstrated that the COP-SAT may be a practical tool for the identification of patients at risk of developing sleep disorders in the community.

show abstract

Clinical services for obstructive sleep apnea patients in pharmacies: the Australian experience

2014

View full text Add to dashboard Cite

show abstract

The development of a sleep disorder screening program in Australian community pharmacies

Cited by 32 publications

References 35 publications

Primary health care practitioner perspectives on the management of insomnia: a pilot study

Primary health care practitioner perspectives on the management of insomnia: a pilot study

Can a community pharmacy sleep assessment tool aid the identification of patients at risk of sleep disorders in the community: a pilot study

Clinical services for obstructive sleep apnea patients in pharmacies: the Australian experience

Contact Info

Product

Resources

About